Capricor Therapeutics Inc. | Small-cap | Healthcare
$10.09
9.08%
| Capricor Stock Comparison:
Capricor vs VertexCapricor vs RegeneronCapricor vs Vera TherapeuticsCapricor vs Immunocore HoldingsCapricor vs AgiosCapricor vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 22.3M
Operating Income -42.6M -191.13%
Net Income -40.5M -181.71%
EPS (Diluted) -$1.15

Balance Sheet Metrics

Total Assets 170.5M
Total Liabilities 25.0M
Shareholders Equity 145.5M
Debt to Equity 0.17

Cash Flow Metrics

Operating Cash Flow -41.6M
Free Cash Flow -41.5M

Revenue & Profitability Trend

Capricor Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 22.3M 25.2M 2.6M 244.9K 310.2K
Cost of Goods Sold - - - - -
Gross Profit - - - - -
Operating Expenses 64.2M 48.8M 32.1M 21.2M 14.0M
Operating Income -42.6M -24.1M -29.7M -20.9M -13.7M
Pre-tax Income -40.5M -22.3M -29.0M -20.0M -13.7M
Income Tax - - - - -
Net Income -40.5M -22.3M -29.0M -20.0M -13.7M
EPS (Diluted) -$1.15 -$0.83 -$1.18 -$0.87 -$0.88

Income Statement Trend

Capricor Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 163.4M 50.9M 42.9M 36.4M 33.7M
Non-Current Assets 7.1M 7.9M 7.2M 4.9M 941.7K
Total Assets 170.5M 58.7M 50.1M 41.3M 34.6M
Liabilities
Current Liabilities 21.0M 31.3M 23.6M 4.1M 3.0M
Non-Current Liabilities 4.0M 4.9M 14.7M 5.8M 3.4M
Total Liabilities 25.0M 36.1M 38.3M 10.0M 6.4M
Equity
Total Shareholders Equity 145.5M 22.6M 11.8M 31.4M 28.2M

Balance Sheet Composition

Capricor Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -40.5M -22.3M -29.0M -20.0M -13.7M
Operating Cash Flow -41.6M -25.5M 4.6M -16.5M -9.6M
Investing Activities
Capital Expenditures -1.5M -2.0M -3.4M -1.2M -547.6K
Investing Cash Flow -116.2M 5.1M -35.1M -1.2M 5.4M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow 152.3M 25.5M 4.8M 20.2M 27.7M
Free Cash Flow -41.5M -27.6M 1.6M -18.0M -10.6M

Cash Flow Trend

Capricor Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -6.68
Forward P/E -10.20
Price to Book 2.96
Price to Sales 21.74
PEG Ratio -10.20

Profitability Ratios

Profit Margin 0.00%
Operating Margin -329.90%
Return on Equity -75.39%
Return on Assets -35.24%

Financial Health

Current Ratio 6.55
Debt to Equity 0.98
Beta 0.85

Per Share Data

EPS (TTM) -$1.37
Book Value per Share $2.80
Revenue per Share $0.45

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
capr 377.5M -6.68 2.96 -75.39% 0.00% 0.98
Vertex 114.1B 32.82 6.92 -5.64% -8.91% 10.00
Regeneron 55.3B 13.02 1.84 15.96% 31.94% 9.20
Vera Therapeutics 1.4B -8.41 2.58 -39.49% 0.00% 10.18
Immunocore Holdings 1.6B -31.41 4.13 -5.86% -6.48% 114.67
Agios 1.9B 2.89 1.32 60.26% 1,798.26% 3.61

Financial data is updated regularly. All figures are in the company's reporting currency.